TY  - JOUR
AU  - García Carbonero, Rocío
AU  - Salazar, Ramon
PY  - 2022
DO  - 10.1136/jitc-2021-003255
SN  - 2051-1426
UR  - https://hdl.handle.net/20.500.14352/117223
T2  - Journal for immunotherapy of cancer
AB  - Background VCN-01 is an oncolytic adenovirus (Ad5 based) designed to replicate in cancer cells with dysfunctional RB1 pathway, express hyaluronidase to enhance virus intratumoral spread and facilitate chemotherapy and immune cells extravasation into...
LA  - eng
PB  - BMJ Publishing Group
KW  - Clinical trials as topic
KW  - Gastrointestinal neoplasms
KW  - Oncolytic virotherapy
KW  - Tumor microenvironment
TI  - Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
TY  - journal article
VL  - 10
ER  -